Health & Science

Many public health experts are now increasingly optimistic about how the pandemic is playing out in the U.S.. Here's what they say we can expect for the rest of 2021.

There’s still a major divide when it comes to race and ethnicity of city vaccine recipients.

The relaxing of visitation rules in long-term care comes as N.J. grapples with a significant surge in new coronavirus infections, as well as an uptick in hospitalizations.

When Pa. relaxes restaurant restrictions on April 4, Philadelphia won’t be following suit, citing a rise in COVID-19 cases and hospitalizations.

The governor said restrictions might be eased in the coming days but is also concerned about a recent uptick in cases and hospitalizations.

The problem arose after a QR code intended for people at the Convention Center to make their second-dose appointments was shared widely.

Affluent countries are hoarding vaccines. So how do you make vaccine distribution more equitable? And what threat does vaccine nationalism pose to the ending the pandemic?

The National Institute of Allergy and Infectious Diseases said the Data Safety and Monitoring Board is concerned "outdated information" may have been included in trial data.

The percentage of New Jerseyans over age 75 — the group most at risk for death from COVID-19 — who have received at least one shot nearly doubled since late February.

The clinic will be open two days a week starting March 29.

For the next three weeks, the site will finish giving second doses of the Pfizer-BioNTech COVID-19 vaccine, but will no longer administer first doses or accept walk-ups.

New Jersey has opened up the state’s long-term care facilities to indoor visits, following federal guidance from the Biden administration. Here’s what you need to know.

Health officials said the new rules also apply to vaccinated people gathering with people from a single household who have not been vaccinated but who are considered low risk.

Enrollment in the program rose by more than 388,000 people, or 13.7%, including in counties that, historically, have been wealthier than some of their counterparts.

Although AstraZeneca’s vaccine has been authorized in more than 50 countries, it has not yet been given the green light in the U.S.